LAVA THERAPEUTICS NV's ticker is LVTX and the CUSIP is N51517105. A total of 20 filers reported holding LAVA THERAPEUTICS NV in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $162,555 | -26.6% | 109,097 | 0.0% | 0.10% | -29.0% |
| Q2 2023 | $221,467 | +11.6% | 109,097 | -8.7% | 0.14% | +98.6% |
| Q1 2023 | $198,397 | -52.6% | 119,516 | 0.0% | 0.07% | -3.9% |
| Q4 2022 | $418,306 | -24.5% | 119,516 | -1.4% | 0.08% | +16.9% |
| Q3 2022 | $554,000 | +59.7% | 121,193 | 0.0% | 0.06% | +80.6% |
| Q2 2022 | $347,000 | -34.9% | 121,193 | 0.0% | 0.04% | -25.0% |
| Q1 2022 | $533,000 | -20.1% | 121,193 | 0.0% | 0.05% | -35.1% |
| Q4 2021 | $667,000 | -19.6% | 121,193 | -13.6% | 0.07% | +15.6% |
| Q3 2021 | $830,000 | -47.4% | 140,229 | -3.2% | 0.06% | -36.6% |
| Q2 2021 | $1,577,000 | -31.0% | 144,902 | -3.7% | 0.10% | -28.9% |
| Q1 2021 | $2,285,000 | – | 150,454 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,070,558 | $5,097,126 | 0.34% |
| Bruce & Co., Inc. | 671,874 | $1,115,311 | 0.30% |
| Redmile Group, LLC | 2,074,372 | $3,443,458 | 0.15% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 140,291 | $232,883 | 0.10% |
| Alpha Wave Global, LP | 119,516 | $198,397 | 0.07% |
| Artal Group S.A. | 200,000 | $332 | 0.02% |
| Cannell Capital | 17,955 | $29,805 | 0.01% |
| CANTOR FITZGERALD, L. P. | 53,299 | $88,476 | 0.00% |
| UBS OCONNOR LLC | 20,502 | $34,033 | 0.00% |
| AXA S.A. | 225,748 | $374,742 | 0.00% |